Pharmaceutical

Botulinum battle heats up with FDA approving Daxxify for cervical dystonia

Daxxify becomes the latest botulinum toxin to make the jump from aesthetics to therapeutics.

Aug 14, 2023 - 20:00
Botulinum battle heats up with FDA approving Daxxify for cervical dystonia
Daxxify becomes the latest botulinum toxin to make the jump from aesthetics to therapeutics.
Read the original article

Tags:

Previous Article

STAT+: Pharma budget tightening trickles down to Doximity

Next Article

LifeArc invests nearly $10m in Crick Institute’s Africa Scheme

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Sanofi Canada’s Dupixent receives approval to treat EoE

Sanofi Canada’s Dupixent receives approval to treat EoE

May 6, 2023

STAT+: House GOP offers new plan to stem drug shortages, including cancer drug shortages

STAT+: House GOP offers new plan to stem drug shortages...

Jul 28, 2023

STAT+: South Africa was forced into ‘one-sided’ deals with Covid-19 vaccine suppliers, contracts reveal

STAT+: South Africa was forced into ‘one-sided’ deals w...

Sep 6, 2023